Dr. Gregory Smith McFadden, MD

Dr. McFadden practices at Oroville Hospital in Oroville, California, part of Oro Hospital.

Dr. McFadden's NPI, 1780622431, was assigned on June 3, 2006. Dr. McFadden graduated from John A. Burns School of Medicine in 1987. Dr. McFadden holds California license G60437.

Dr. McFadden's primary practice is Oroville Hospital, at 2767 Olive Highway, Oroville, CA 95966 in Butte County. The practice phone is (530) 533-8500.

Dr. McFadden's primary practice is Oroville Hospital in Oroville, California, part of Oro Hospital. Dr. McFadden is also affiliated with Enloe Health. The medical group on file is Butte County Department of Behavioral Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McFadden practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. McFadden's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. McFadden is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. McFadden's licenses on file in 3 states: California, Hawaii and Maryland.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression and schizophrenia among the conditions Dr. McFadden treats.

CMS data shows 364 Medicare services from Dr. McFadden across 2 procedure codes in 2024, all of them office visits, for 82 Medicare patients. Medicare paid $26,030 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. McFadden in 2024. The largest group is under 65, with 54 patients. 70% of them have schizophrenia and other psychoses, and 61% have mood disorders. 100% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McFadden's median patient age at 45, with 53% women.

In 2024, Dr. McFadden wrote 3,137 Medicare Part D claims for 96 patients. 89% of them were for generic drugs. CMS names the drug for 3,033 of them, across 53 drugs with 11 or more claims each, at $758,988 in total drug cost. In 2023, CMS named 3,800 claims across 63 drugs.

Dr. McFadden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. McFadden from 5 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $200.

Dr. McFadden graduated from John A. Burns School of Medicine in 1987.

Dr. McFadden is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.